• Home
  • About Us
    • About Us
    • Subscribe
    • Privacy Policy
  • Advertise
    • Advertise On IP Watch
    • Editorial Calendar
  • Videos
  • Links
  • Help

Intellectual Property Watch

Original news and analysis on international IP policy

  • Copyright
  • Patents
  • Trademarks
  • Opinions
  • People News
  • Venues
    • Bilateral/Regional Negotiations
    • ITU/ICANN
    • United Nations – other
    • WHO
    • WIPO
    • WTO/TRIPS
    • Africa
    • Asia/Pacific
    • Europe
    • Latin America/Caribbean
    • North America
  • Themes
    • Access to Knowledge/ Open Innovation & Science
    • Food Security/ Agriculture/ Genetic Resources
    • Finance
    • Health & IP
    • Human Rights
    • Internet Governance/ Digital Economy/ Cyberspace
    • Lobbying
    • Technical Cooperation/ Technology Transfer
  • Health Policy Watch

UN Panel On Access To Medicines Extends Deadline For Contributions

15/02/2016 by Intellectual Property Watch 2 Comments

Share this:

  • Click to share on Twitter (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to email this to a friend (Opens in new window)
  • Click to print (Opens in new window)

The United Nations High-Level Panel on Access to Medicines has announced that the deadline for the submission of stakeholders’ contributions has been extended to 28 February 2016. The panel also lifted restrictions on the number of contributions authors can submit.

The previous deadline for contributions was 18 February (IPW, Public Health, 1 February 2016) and (IPW, Public Health, 5 February 2016).

According to the panel, the extension of the deadline follows feedback from “several partners.” During the presentation of the High-Level Panel in Geneva at the end of January, a representative from the pharmaceutical industry had remarked on the short time allowed for submissions.

The panel is calling for contributions from “all related stakeholders in, but not limited to, government, the private sector, research institutions, non-profit organizations, academic institutions, legal experts and patient groups that address the policy incoherence between international human rights law, trade rules and public health objectives.”

Share this:

  • Click to share on Twitter (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to email this to a friend (Opens in new window)
  • Click to print (Opens in new window)

Related

Creative Commons License"UN Panel On Access To Medicines Extends Deadline For Contributions" by Intellectual Property Watch is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Filed Under: IP-Watch Briefs, IP Policies, Language, Themes, Venues, English, Health & IP, Innovation/ R&D, Patents/Designs/Trade Secrets, United Nations - other, WHO

Trackbacks

  1. Links 16/2/2016: FOSS Search Engine of Wikipedia, Street Fighter V on GNU/Linux | Techrights says:
    16/02/2016 at 11:53 am

    […] UN Panel On Access To Medicines Extends Deadline For Contributions […]

    Reply
  2. IFPMA Interview: Antimicrobial Resistance, Regulatory Systems High On Pharma Industry 2016 Agenda says:
    17/02/2016 at 2:23 pm

    […] UN Panel On Access To Medicines Extends Deadline For Contributions […]

    Reply

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

  • Email
  • Facebook
  • LinkedIn
  • RSS
  • Twitter
  • Vimeo
My Tweets

IPW News Briefs

Saudis Seek Alternative Energy Partners Through WIPO Green Program

Chinese IP Officials Complete Study Of UK, European IP Law

Perspectives on the US

In US, No Remedies For Growing IP Infringements

US IP Law – Big Developments On The Horizon In 2019

More perspectives on the US...

Supported Series: Civil Society And TRIPS Flexibilities

Civil Society And TRIPS Flexibilities Series – Translations Now Available

The Myth Of IP Incentives For All Nations – Q&A With Carlos Correa

Read the TRIPS flexibilities series...

Paid Content

Interview With Peter Vanderheyden, CEO Of Article One Partners

More paid content...

IP Delegates in Geneva

  • IP Delegates in Geneva
  • Guide to Geneva-based Public Health and IP Organisations

All Story Categories

Other Languages

  • Français
  • Español
  • 中文
  • اللغة العربية

Archives

  • Archives
  • Monthly Reporter

Staff Access

  • Writers

Sign up for free news alerts

This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy

Copyright © 2025 · Global Policy Reporting

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.